Literature DB >> 2453576

Selective synthesis of mRNA and proteins by human peripheral blood neutrophils.

R M Jack1, D T Fearon.   

Abstract

Human peripheral blood polymorphonuclear neutrophils (PMN) have been considered to be capable of little if any protein biosynthesis. We evaluated the ability of PMN to synthesize both mRNA and proteins. Using in vitro [35S]methionine pulse-chase labeling of purified PMN, followed by immunoprecipitation of cell lysates with immobilized mAb and analysis by gel electrophoresis, PMN were shown to synthesize CR1, FcR, CR3 alpha-chain, MHC class I, and actin. In contrast, incorporation of [35S]methionine into either CR3 beta-chain or the secondary granule protein lactoferrin was not detected. Purification of mRNA from PMN and analysis by Northern blots demonstrated the presence in PMN of CR1, actin, and MHC class I transcripts. However, despite the apparent lack of CR3 beta-chain biosynthesis, specific beta-chain message was detectable in PMN RNA. Inhibition of mRNA synthesis in PMN with actinomycin D resulted in decreased synthesis of nascent CR1, FcR, MHC class I, and actin compared with control cells. Thus, PMN continue to transcribe and translate the genes for certain membrane and cytoskeletal proteins. In contrast, the lack of detectable synthesis of either lactoferrin or CR3 beta-chain suggested that biosynthesis in circulating PMN is selective.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453576

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Potentiation of the respiratory burst of human neutrophils by cycloheximide: regulation of reactive oxidant production by a protein(s) with rapid turnover?

Authors:  R E Stringer; S W Edwards
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

2.  Cord blood CD8+ T-cell expansion following granulocyte transfusions eradicates refractory leukemia.

Authors:  Prashant Hiwarkar; Stuart Adams; Kimberly Gilmour; Ramya Nataraj; Denise Bonney; Kay Poulton; Robert Wynn
Journal:  Blood Adv       Date:  2020-09-08

3.  Synthesis of aberrant decay-accelerating factor proteins by affected paroxysmal nocturnal hemoglobinuria leukocytes.

Authors:  D J Carothers; S V Hazra; S W Andreson; M E Medof
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

4.  Sequences of complementary DNAs that encode the NA1 and NA2 forms of Fc receptor III on human neutrophils.

Authors:  P A Ory; M R Clark; E E Kwoh; S B Clarkson; I M Goldstein
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

5.  Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes.

Authors:  P C Lord; L M Wilmoth; S B Mizel; C E McCall
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Circulating human peripheral blood granulocytes synthesize and secrete tumor necrosis factor alpha.

Authors:  D B Dubravec; D R Spriggs; J A Mannick; M L Rodrick
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus.

Authors:  M R Clark; L Liu; S B Clarkson; P A Ory; I M Goldstein
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

8.  Antigen-specific cytolysis of infected cells in murine candidiasis.

Authors:  L Romani; S Mocci; E Cenci; A Mencacci; G Sbaraglia; P Puccetti; F Bistoni
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

9.  Francisella tularensis alters human neutrophil gene expression: insights into the molecular basis of delayed neutrophil apoptosis.

Authors:  Justin T Schwartz; Sarmistha Bandyopadhyay; Scott D Kobayashi; Jenna McCracken; Adeline R Whitney; Frank R Deleo; Lee-Ann H Allen
Journal:  J Innate Immun       Date:  2012-09-14       Impact factor: 7.349

10.  NADPH-oxidase activity of stimulated neutrophils is markedly increased by serum.

Authors:  A J Theron; K J Steenkamp; R Anderson
Journal:  Inflammation       Date:  1994-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.